Corrigendum to “The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease” [Biomed. Pharmacother. 159 (2023) 114223] - 13/08/23
Doi : 10.1016/j.biopha.2023.115226
Martin Valis a, Alzbeta Dlabkova b, Jakub Hort c, d, Francesco Angelucci c, d, Jaroslav Pejchal b, Kamil Kuca a, e, Zbysek Pavelek a, Jana Zdarova Karasova b, e, Michal Novotny a, ⁎ 
a Department of Neurology, Faculty of Medicine and University Hospital Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
b Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, the University of Defense in Brno, Hradec Kralove, Czech Republic
c Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
d International Clinical Research Center, St. Anne’s University Hospital Brno, Brno, Czech Republic
e Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2023
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 165
Article 115226- septembre 2023 Retour au numéro
Article précédent
- Corrigendum to “A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer” [Biomed. Pharmacother. 117 (2019) 109072]
- Xin Li, Xiuhua Wu, Hongyu Yang, Lin Li, Ziqi Ye, Yuefeng Rao
- Retraction notice to “MicroRNA-497 promotes proliferation and inhibits apoptosis of cardiomyocytes through the downregulation of Mfn2 in a mouse model of myocardial ischemia-reperfusion injury” [Biomed. Pharmacother. 105 (2018) 103–114]
- Lei Qin, Wen Yang, Yao-Xin Wang, Zhen-Jun Wang, Chen-Chen Li, Man Li, Jie-Yun Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?